CCI Clears Torrent's Acquisition of JB Chemicals Stake

The Competition Commission of India (CCI) on Tuesday approved Torrent Pharmaceuticals Ltd’s proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, contingent upon certain voluntary modifications submitted by both companies.This approval follows Torrent Pharmaceuticals’ June 2025 announcement of its plan to acquire a majority stake in JB Chemicals through a ?19,500-crore deal.

"The proposed combination relates to the acquisition of shareholding by Torrent Pharmaceuticals Ltd (acquirer) in JB Chemicals & Pharmaceuticals Ltd (target) and the subsequent amalgamation of the target with the acquirer," the regulator said in a release.Upon completion of the acquisition, Torrent Pharmaceuticals is set to become the second most valuable pharmaceutical company in India.

Also Read: FDA Approves Amgen TEZSPIRE for Chronic Rhinosinusitis

"The Commission approved the proposed combination subject to compliance with voluntary modifications offered by the parties (Torrent Pharmaceuticals Ltd and JB Chemicals & Pharmaceuticals Ltd)," it added.

Torrent Pharmaceuticals, the flagship entity of the Torrent Group, specializes in the manufacturing and distribution of pharmaceutical formulations (FDFs) across a variety of therapeutic areas.

Meanwhile, JB Chemicals and Pharmaceuticals operates in the production and marketing of a wide portfolio of FDFs and active pharmaceutical ingredients (APIs). The company also offers contract development and manufacturing organization (CDMO) services, catering to diverse industry needs.